Vydura is a medicine used to treat migraine with or without aura (unusual visual or other sensory experiences) in adults. It is also used to prevent migraine in adults who have at least 4 migraines attacks a month. Vydura contains the active substance rimegepant.
Therapeutic Indication
Vydura is indicated for the * Acute treatment of migraine with or without aura in adults; * Preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
Therapeutic Area (MeSH)
ATC Code
N02CD06
ATC Item
N/A
Pharmacotherapeutic Group
Antimigraine preparations, calcitonin gene-related peptide (CGRP) antagonists
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| rimegepant | N/A | rimegepant |
EMA Name
Vydura
Medicine Name
Vydura
Aliases
N/ANo risk management plan link.
